REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

8 Feb 2019 09:00

RNS Number : 4320P
Circassia Pharmaceuticals Plc
08 February 2019
 

8 February 2019

 

 

Circassia Pharmaceuticals plc

 

Notice of Preliminary Results

 

 

Circassia Pharmaceuticals plc (LSE: CIR) will announce its preliminary results for the year ended 31 December 2018 on Wednesday 1 May 2019.

 

A presentation for analysts will take place at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am. A webcast of the presentation will be available on the Company's website.

 

 

Contacts

Circassia

Steve Harris, Chief Executive Officer Tel: +44 (0) 1865 405 560

Julien Cotta, Chief Financial Officer

Rob Budge, Corporate Communications

 

Peel Hunt (Nominated Adviser and Joint Broker)

James Steel / Dr Christopher Golden Tel: +44 (0) 20 7418 8900

 

Numis Securities (Joint Broker)

James Black / Freddie Barnfield Tel: +44 (0) 20 7260 1000

 

FTI Consulting

Simon Conway / Ciara Martin Tel: +44 (0) 20 3727 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORFMGGZNNDGLZM
Date   Source Headline
1st Sep 20225:45 pmRNSChange of Company Name
1st Sep 202211:00 amRNSResult of General Meeting and Change of Name
11th Aug 20227:00 amRNSProposed Change of Name and Notice of GM
29th Jul 202210:41 amRNSTotal Voting Rights
21st Jul 20223:30 pmRNSChange of Auditor
14th Jul 20227:00 amRNSTrading Update
5th Jul 20223:57 pmRNSHolding(s) in Company
30th Jun 202211:54 amRNSTotal Voting Rights
29th Jun 202211:00 amRNSUpdate regarding Beyond Air product approval
10th Jun 20221:06 pmRNSHolding(s) in Company
31st May 202211:08 amRNSTotal Voting Rights
27th May 20229:53 amRNSExtension of Block Admission
25th May 20224:41 pmRNSSecond Price Monitoring Extn
25th May 20224:35 pmRNSPrice Monitoring Extension
20th May 20227:00 amRNSGrant of Options
12th May 202212:04 pmRNSResult of AGM
12th May 20227:00 amRNSAGM Statement
3rd May 20224:01 pmRNSChange of Registered Office
29th Apr 202210:32 amRNSTotal Voting Rights
13th Apr 20226:17 pmRNSAnnual Report and Notice of AGM
1st Apr 20227:00 amRNSBlock listing Interim Review
1st Apr 20227:00 amRNSTotal Voting Rights
29th Mar 20222:18 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSBlock Admission
22nd Mar 20227:00 amRNSPreliminary Results
31st Jan 202210:24 amRNSTotal Voting Rights
28th Jan 20222:15 pmRNSHolding(s) in Company
13th Jan 20227:00 amRNSTrading Statement
4th Jan 202210:40 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSTotal Voting Rights
29th Nov 20218:54 amRNSBlock Listing Application
5th Oct 20213:06 pmRNSExtension of Block Admission
30th Sep 20213:15 pmRNSBlock listing Interim Review
21st Sep 20215:18 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSDirector/PDMR Shareholding
16th Sep 20217:00 amRNSInterim Results - Ended 30 June 2021
1st Sep 20212:52 pmRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
13th Jul 20217:00 amRNSFirst Half Trading Update
30th Jun 202111:15 amRNSTotal Voting Rights
26th May 20217:00 amRNSSettlement Agreement reached with Beyond Air
21st May 202110:58 amRNSResult of AGM
21st May 20217:00 amRNSAGM Statement
5th May 20216:30 pmRNSHolding(s) in Company
30th Apr 202112:32 pmRNSTotal Voting Rights
21st Apr 20217:00 amRNSAnnual Report and Notice of AGM
6th Apr 202112:56 pmRNSDirector/PDMR Shareholding
1st Apr 20219:00 amRNSBlock Listing Application
31st Mar 202112:14 pmRNSBlock listing Interim Review
24th Mar 20217:01 amRNSSubscription to raise £5 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.